Diclofenac Potassium With Lidocaine Cream in Reducing Pain During HSG
DP-L
Randomized Clinical Trial of Oral Diclofenac Potassium With Cervical Lidocaine Cream in Reducing Pain During HSG
1 other identifier
interventional
140
1 country
1
Brief Summary
The aim of our study is to determine the efficacy of oral diclofenac potassium combined with lidocaine cream on the pain scores during HSG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Mar 2016
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 11, 2016
CompletedFirst Posted
Study publicly available on registry
March 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedApril 26, 2017
April 1, 2017
3 months
March 11, 2016
April 25, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Mean pain score during hysterosalpigography by visual analog scale
intraoperative
Secondary Outcomes (2)
Mean pain score after hysterosalpigography
30 minutes
side effects of medication
30 minutes
Study Arms (2)
Group A
EXPERIMENTALoral diclofenac potassium plus lidocaine anesthetic cream placed into their cervix immediately before HSG
Group B
PLACEBO COMPARATORoral placebo tablets plus placebo cream placed into their cervix immediately before HSG
Interventions
patients will have of oral diclofenac potassium 60 minutes before the procedure plus lidocaine anesthetic cream placed into their cervix immediately before HSG
patients will have of oral placebo tablet 60 minutes before the procedure plus placebo cream placed into their cervix immediately before HSG
Eligibility Criteria
You may qualify if:
- any patient came for HSG
You may not qualify if:
- any patient has contraindication to HSG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmed Abbas
Assiut, Cairo Governorate, 002, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
March 11, 2016
First Posted
March 16, 2016
Study Start
March 1, 2016
Primary Completion
June 1, 2016
Study Completion
July 1, 2016
Last Updated
April 26, 2017
Record last verified: 2017-04